Industry insights
Stay ahead with expert perspectives, innovative solutions, and the latest trends in clinical trial optimization.

Introducing the Clinials Refer & Generate Partner Program

What Save Our Sites Reminded Us About What Matters in Clinical Research

Sites Are Losing Money on Every Proposal. Here's Why and What We Built to Fix It

The Human Cost of Unclear Work and Why Clarity Is Now an Economic Imperative in Clinical Trials

How Clinials Supports Medical Device Companies Entering the U.S. Market

The cognitive load required to translate complex protocol information into actionable knowledge

Using Plain Language to Communicate Research to a Broad Audience

The Hidden Cost of General-Purpose AI!

Are You Ready for JPM Week 2026? The 360° Investor Readiness Guide for Biotechs Raising Capital

Reclaiming Time in Clinical Trials: If You’re Overloaded, This Is for You

The Hidden Engine of Clinical Trials: Why Consultants Matter More Than You Think

People need people: the recruitment crisis in clinical trials

Technology Adoption in Clinical Research: Why Lightweight Tools Remain an Untapped Advantage

When Complexity Becomes a Business Risk: Why More Sites Are Turning Down Trials

From Compliance to Connection: How Clinical Trial Marketing Is Evolving

The Compliance-Built Future of AI in Clinical Trials

From Compliance to Clarity: A Frontline View of Clinical Trials

The Hidden Architecture of Clinical Trials: What 350,000+ Studies Reveal About Patient Eligibility

Beyond the NDA: Building Real Trust in the Clinical Trials Industry

The Clinical Trial Reset Is Happening

Too Busy to Try Anything New? That Might Be the Problem.

Re-Humanizing Clinical Trials: Lessons from an Honest Conversation

The Global Trials Race: How Speed, Scale, and Smart Tech Will Redefine Biotech Competitiveness

From Templates to Tailored: The Future of Clinical Documents

The Real Cost of Doing Nothing in the Clinical Trials Industry

Pacing Matters: Knowing When to Accelerate and When to Slow Down in a Clinical Trial

From ARCS 2025, AI in Clinical Trials: Between Promise, Practicality, and People

Why We’re Going to BIO

From Compliance to Connection: The Human Case for Plain Language Protocol Synopses

Real Talk from MAGI 2025: What the Industry’s Actually Thinking

The FDA Just Went All-In on AI. What That Means for Clinical Trials

Then and Now: Innovation in Its Time

Clinials, ChatGPT, Copilot, which AI platform is fit for purpose in clinical trials?

Marketing Best Practice for Clinical Trials: A Study

The AI Paradox in Clinical Trials: Sponsors Adopt It, Others Resist

The Human Behind the AI: How Maree Beare is Making Clinical Trials Work for Everyone

Designing for the Invisible Patient

At the Fork in the Road: Why Clinical Trials Must Speak with Clarity

Breaking the Bottleneck: Reimagining Site Start-Up in Clinical Trials

Navigating the Storm in Clinical Trials

Patient Engagement Strategies for 2025: Breaking the Mold

Solving Patient Recruitment Challenges in Clinical Trials

How Marketing is Reshaping the Clinical Trial Experience

The Growing Challenge of PI Shortages in Clinical Trials: A Call to Action

The Role of AI in Decentralized Trials: Hype or Reality?

Decentralized & Hybrid Clinical Trials: The Future of Patient-Centric Research

AI for Clinical Trials: Reducing Site Burden & Enhancing Patient Engagement

Plain Language Matters: Rethinking Informed Consent in Clinical Trials

After Trump Executive Orders, FDA Removes Diversity Guidance

Is AI Safe for Clinical Trials? Dispelling Myths and Ensuring Compliance

AI and Automation in Clinical Trials: Opportunities, Challenges, and ROI

Transforming Clinical Trial Operations with AI-Driven Document Automation

Maximizing ROI with Clinials: How Our Platform Streamlines Clinical Trial Operations

Key Pain Points for CRO’s and Sites

What is a Plain Language Protocol Synopsis (PLPS)

What Artificial Intelligence (AI) works BEST for you?

How Clinials is Building Safety into its AI Platform
